Trial Profile
Clinical Trials Insight: 700056500
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 May 2010
Price :
$35
*
At a glance
- Drugs OXY 111A (Primary)
- Indications Cancer; Chronic heart failure
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- Sponsors NormOxys
- 24 May 2010 Trial has been initiated according to a NormOxys media release.
- 24 May 2010 New trial record